Physician Wealth Advisors’s Roivant Sciences ROIV Stock Holding History

Physician Wealth Advisors’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$602	Buy	+17	New	+$502	﹤0.01%	2022

Other funds holding ROIV

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Penn Davis McFarland Dallas, Texas $1.12B AUM 32.35% 1-Year Est. Return

Cache Advisors San Francisco, California $1.18B AUM 44.04% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

Edge Wealth Management New York $594M AUM 24.92% 1-Year Est. Return

Physician Wealth Advisors's ROIV Position: Q2 2026 in Review

Physician Wealth Advisors opened a new position in Roivant Sciences (ROIV) in Q2 2026: 17 shares worth $602. The stake represents ﹤0.01% of the portfolio and ranks #2022 among its holdings.

57 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Physician Wealth Advisors held 17 shares of Roivant Sciences worth $602 as of Q2 2026.
Roivant Sciences was a new Physician Wealth Advisors position in Q2 2026.
Roivant Sciences made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q2 2026, its #2022 holding.
57 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Physician Wealth Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.